Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Corrigendum
Current Issue
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letters to Editor
Literature Review
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Allied Health Professionals’ Corner
Author Reply
Book Review
Brief Communication
Case Report
Case Series
Clinical Case Report
Clinicopathological Conference
Commentary
Corrigendum
Current Issue
Editorial
Editorial – World Kidney Day 2016
Editorial Commentary
Erratum
Foreward
Guideline
Guidelines
Image in Nephrology
Images in Nephrology
In-depth Review
Letter to Editor
Letter to the Editor
Letters to Editor
Literature Review
Notice of Retraction
Obituary
Original Article
Perspective
Research Letter
Retraction Notice
Review
Review Article
Short Review
Special Article
Special Feature
Special Feature - World Kidney Day
Systematic Review
Technical Note
Varia
View/Download PDF

Translate this page into:

Letter to Editor
30 (
2
); 137-138
doi:
10.4103/ijn.IJN_78_19

AL Amyloidosis in a Patient with IgD Myeloma

Department of Nephrology, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, University Mohammed V-Souissi, Rabat, Morocco
Department of Biochemistry, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, University Mohammed V-Souissi, Rabat, Morocco

Address for correspondence: Dr. Hicham Rafik, Department of Nephrology, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, University Mohammed V-Souissi, Rabat, Morocco. E-mail: rafikhicham7@gmail.com

Licence

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.

Sir,

Multiple myeloma associated with IgD monoclonal protein is a well-recognized, but rare entity that affect less than 2% of patients with multiple myeloma.[1]

Many studies including patients with IgD multiple myeloma have been published to date.[23456] This entity appears to have clinical and evolutionary differences compared with non-IgD myeloma, including a younger age at disease presentation, a higher incidence of kidney injury and a poor prognosis. A 55 years old male, with pulmonary tuberculosis in 2007, presented with lower limbs edema, dyspnea and upper limbs paresthesia for the past 4 months. He did not have bone pain. Physical examination revealed peripheral edema, macroglossia, periorbital petechial and ecchymotic lesions. There was no peripheral lymphadenopathy and no hepatosplenomegaly.

Laboratory results were as follows: serum albumin 27 g/l, total serum proteins 47 g/l, 24 hours urine protein 7 g, hematuria 3 × 104/ml, serum creatinine: 0.6 mg/dl, serum potassium: 3.7 mEq/l, serum calcium 11.3 mg/dl, hemoglobin: 11.3 g/dl, white cell count: 9.2 × 109/l and platelet count: 314 × 109/l. A renal biopsy was performed. It revealed eleven glomeruli. Three of them were sclerosed. Remaining glomeruli revealed acellular, amorphous, pale pink deposits with Congo red positivity and apple-green birefringence under polarized light. Immunofluorescence revealed that staining for lambda light chain was positive and staining for kappa light chain was negative. AL amyloidosis diagnosis was retained.

Serum protein electrophoresis showed hypogammaglobinemia 2.66 g/l that evoked free light chain myeloma [Figure 1]. Therefore, we systematically completed routine serum protein immunofixation by testing for IgD and IgE that revealed IgD lambda monoclonal immunoglobulin. Urine protein immunofixation showed lambda monoclonal free light chains at a high concentration [Figure 2]. The serum levels were IgG: 3.04 g/l, IgA: 0.18 g/l, IgM: 0.11 g/l, kappa free light chain: 0.94 mg/dl, lambda free light chain: 1218.84 mg/dl and kappa to lambda ratio <0.09. Bone marrow aspiration showed a marrow invaded by 60% of dystrophic plasma cells confirming multiple myeloma.

Serum protein electrophosis showed hypogammaglobinema
Figure 1
Serum protein electrophosis showed hypogammaglobinema
(a) Serum protein immunofixation revealed IgD lambda monoclonal immunoglobulin. (b) Urine protein immunofixation showed lambda monoclonal free light chain
Figure 2
(a) Serum protein immunofixation revealed IgD lambda monoclonal immunoglobulin. (b) Urine protein immunofixation showed lambda monoclonal free light chain

Standard skeletal imaging was done and was found normal. Echocardiography revealed dilated left ventricle, anterolateral hypokinesis, and good systolic function with ejection fraction at 55%. Coronary angiography showed spastic atheroma.

Due to severe cardiac involvement, (Mayo Clinic stage 4: Troponin T: 138 ng/l, N-terminal propeptide of brain natriuretic peptide: 9380 ng/l, serum free light chain difference: 12179 mg/l),[78] a bortezomib-cyclophosphamide-dexamethasone regimen was used for the treatment. Unfortunately, after one cycle, the patient died of myocardial infarction.

IgD amyloidosis is rare. Among 3955 patients with AL amyloidosis seen at Mayo Clinic during a period of 41 years, 53 patients (1.3%) had a serum IgD monoclonal protein. Those patients had a lower frequency of renal and cardiac involvement and had similar survival than their non-IgD counterparts.[9]

The diagnosis of IgD amyloidosis can be difficult. In fact, the IgD monoclonal level is often small and immunofixation in search of IgD is not systematically performed. Therefore, many cases could be unnoticed or taken for a light chain myeloma.[10]

Patients, in whom electrophoresis evoke the presence of monoclonal free light chains, should also be tested for the presence of both IgE and IgD.[11]

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. , , , , , , . Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21-33.
    [Google Scholar]
  2. , , , , . IgD multiple myeloma: Review of 133 cases. Arch Intern Med. 1975;135:87-93.
    [Google Scholar]
  3. , , , , , . Immunoglobulin D myeloma and amyloidosis: Immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins. Blood. 1975;46:713-22.
    [Google Scholar]
  4. , , , , , . IgD multiple myeloma: A clinical profile and outcome with chemotherapy and autologous stem cell transplantation. Ann Hematol. 2005;84:115-7.
    [Google Scholar]
  5. , , . IgD monoclonal gammopathy with long-term follow-up. Br J Haematol. 1994;88:395-6.
    [Google Scholar]
  6. , , , , , , . Immunoglobulin D multiple myeloma: Response to therapy, survival, and prognostic factors in 75 patients. Ann Oncol. 2011;22:411-6.
    [Google Scholar]
  7. , , , , , , . Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis. J Clin Oncol. 2004;22:3751-7.
    [Google Scholar]
  8. , , , , , , . Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30:989-95.
    [Google Scholar]
  9. , , , , , , . Immunoglobulin D amyloidosis: A distinct entity. Blood. 2012;119:44-8.
    [Google Scholar]
  10. , , , . Case report: IgD-Kappa myeloma: An unusual case. Ann Clin Lab Sci. 2003;33:97-100.
    [Google Scholar]
  11. , , . Unusual myelomas: A review of IgD and IgE variants. Oncology (Williston Park). 2013;27:798-803.
    [Google Scholar]
Show Sections